Hepatitis B / / Luis Rodrigo, editor.
Current pharmacologic therapies for chronic hepatitis B virus (HBV) infection allow viral suppression and normalization of the liver enzyme alanine aminotransferase (ALT) and prevent liver disease from progressing. The currently available antiviral therapies very rarely lead to a functional cure. Th...
Saved in:
TeilnehmendeR: | |
---|---|
Place / Publishing House: | London : : IntechOpen,, 2022. |
Year of Publication: | 2022 |
Language: | English |
Physical Description: | 1 online resource (126 pages) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993603750404498 |
---|---|
ctrlnum |
(CKB)5850000000050400 (NjHacI)995850000000050400 (EXLCZ)995850000000050400 |
collection |
bib_alma |
record_format |
marc |
spelling |
Hepatitis B / Luis Rodrigo, editor. London : IntechOpen, 2022. 1 online resource (126 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Description based on publisher supplied metadata and other sources. Current pharmacologic therapies for chronic hepatitis B virus (HBV) infection allow viral suppression and normalization of the liver enzyme alanine aminotransferase (ALT) and prevent liver disease from progressing. The currently available antiviral therapies very rarely lead to a functional cure. Thus, the future of a cure for HBV lies in triple combination therapies with concerted action on replication inhibition, antigen reduction, and immune stimulation. This book reviews the mechanisms and pathogenesis of HBV, as well as discusses current and potential future treatments. Hepatoma. Liver Tumors. 1-80355-008-2 Rodrigo, Luis, editor. |
language |
English |
format |
eBook |
author2 |
Rodrigo, Luis, |
author_facet |
Rodrigo, Luis, |
author2_variant |
l r lr |
author2_role |
TeilnehmendeR |
title |
Hepatitis B / |
spellingShingle |
Hepatitis B / |
title_full |
Hepatitis B / Luis Rodrigo, editor. |
title_fullStr |
Hepatitis B / Luis Rodrigo, editor. |
title_full_unstemmed |
Hepatitis B / Luis Rodrigo, editor. |
title_auth |
Hepatitis B / |
title_new |
Hepatitis B / |
title_sort |
hepatitis b / |
publisher |
IntechOpen, |
publishDate |
2022 |
physical |
1 online resource (126 pages) |
isbn |
1-80355-008-2 |
callnumber-first |
R - Medicine |
callnumber-subject |
RC - Internal Medicine |
callnumber-label |
RC280 |
callnumber-sort |
RC 3280 L5 H473 42022 |
illustrated |
Not Illustrated |
dewey-hundreds |
600 - Technology |
dewey-tens |
610 - Medicine & health |
dewey-ones |
616 - Diseases |
dewey-full |
616.99436 |
dewey-sort |
3616.99436 |
dewey-raw |
616.99436 |
dewey-search |
616.99436 |
work_keys_str_mv |
AT rodrigoluis hepatitisb |
status_str |
n |
ids_txt_mv |
(CKB)5850000000050400 (NjHacI)995850000000050400 (EXLCZ)995850000000050400 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Hepatitis B / |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1796653233191518208 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01439nam a2200289 i 4500</leader><controlfield tag="001">993603750404498</controlfield><controlfield tag="005">20230704203500.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr |||||||||||</controlfield><controlfield tag="008">230704s2022 enk o 000 0 eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5850000000050400</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(NjHacI)995850000000050400</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995850000000050400</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">NjHacI</subfield><subfield code="b">eng</subfield><subfield code="e">rda</subfield><subfield code="c">NjHacl</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RC280.L5</subfield><subfield code="b">.H473 2022</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">616.99436</subfield><subfield code="2">23</subfield></datafield><datafield tag="245" ind1="0" ind2="0"><subfield code="a">Hepatitis B /</subfield><subfield code="c">Luis Rodrigo, editor.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">London :</subfield><subfield code="b">IntechOpen,</subfield><subfield code="c">2022.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (126 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="588" ind1=" " ind2=" "><subfield code="a">Description based on publisher supplied metadata and other sources.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Current pharmacologic therapies for chronic hepatitis B virus (HBV) infection allow viral suppression and normalization of the liver enzyme alanine aminotransferase (ALT) and prevent liver disease from progressing. The currently available antiviral therapies very rarely lead to a functional cure. Thus, the future of a cure for HBV lies in triple combination therapies with concerted action on replication inhibition, antigen reduction, and immune stimulation. This book reviews the mechanisms and pathogenesis of HBV, as well as discusses current and potential future treatments.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Hepatoma.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Liver</subfield><subfield code="x">Tumors.</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">1-80355-008-2</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rodrigo, Luis,</subfield><subfield code="e">editor.</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-07-08 12:22:00 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-08-07 00:20:11 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5339197030004498&Force_direct=true</subfield><subfield code="Z">5339197030004498</subfield><subfield code="b">Available</subfield><subfield code="8">5339197030004498</subfield></datafield></record></collection> |